54 results
8-K
EX-10.1
FENC
Fennec Pharmaceuticals Inc
21 Mar 24
Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand
4:02pm
concerning health, meaning personal data related to the physical or mental health of a natural person, including the provision of health care services
8-K
EX-99.1
FENC
Fennec Pharmaceuticals Inc
2 Feb 24
FDA Issues Reminder of Non-Substitution of PEDMARKÒ (sodium thiosulfate injection) for Pediatric Patients Receiving Cisplatin
12:00am
to match the strength of PEDMARK. The FDA reminded health care providers that as stated in PEDMARK’s prescribing information, PEDMARK is not substitutable
424B5
6era2a0
1 May 20
Prospectus supplement for primary offering
5:28pm
424B5
zlg6 u3ulfbxw
29 Apr 20
Prospectus supplement for primary offering
4:48pm
8-K
EX-10.1
rfnwhkltbo ov6
4 Feb 19
Fennec Pharmaceuticals Announces $12.5 Million Debt Financing with Bridge Bank
2:26pm
D
lmwo7gp9fw e5iozk
15 Dec 14
$2.2M in equity, sold $2.2M, 22 investors
12:00am
424B3
cp3 2nzsjpiqcl
21 Apr 14
Prospectus supplement
12:00am